United States Nanobodies Market is Segmented By Product Type (Monovalent Nanobodies, Bivalent Nanobo....
Market Size in USD Mn
CAGR17.3%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 17.3% |
Market Concentration | Medium |
Major Players | Merck KGaA, Sanofi, GenScript, Numab Therapeutics, CUSABIO TECHNOLOGY LLC and Among Others |
The United States Nanobodies Market is estimated to be valued at USD 109.87 Mn in 2024 and is expected to reach USD 334.97 Mn by 2031, growing at a compound annual growth rate (CAGR) of 17.3% from 2024 to 2031.
Factors such as increasing investment in research and development for production of nanobodies for various therapeutic applications, rising demand for nanobodies due to their high specificity and ability to target complex epitopes are driving the market growth.